Glaucoma Therapeutics Market By Drug Class (Prostaglandins Analogs, Beta Blockers, Alpha-Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Fixed-Dose Combinations) - Growth, Future Prospects And Competitive Analysis 2017 - 2025

Glaucoma is chronic, degenerative disorder that damages the eye's optic nerve, may result in vision loss and blindness. Factors such, high prevalence of glaucoma, technological advancement in diagnostic technique, rising treatment awareness are driving the market growth of glaucoma therapeutics globally.

The report titled “Glaucoma Therapeutics Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall glaucoma therapeutics market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on drug class and different geographical regions.  

In order to help strategic decision makers, the report also includes competitive profiling of the leading players in global glaucoma therapeutics market, attractive investment proposition and market positioning of key manufacturers sections. Other in-depth analysis provided in the report includes:

Geographically, the global glaucoma therapeutics market is studied for the following regional markets:   

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East and Africa

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global glaucoma therapeutics market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global glaucoma therapeutics market. This report concludes with company profiles section that highlights major information about the key players engaged in global glaucoma therapeutics market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global glaucoma therapeutics market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Glaucoma Therapeutics Market

Choose License Type
Published Date:  May 2017
Category:  Pharmaceuticals
Report ID:   58436
Report Format:   PDF
Pages:   120
Rating:    4.3 (50)
Connect With Us
24/7 Research Support